Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nunoya, Ken‐ichi
21  Ergebnisse:
Personensuche X
?
1

Species Difference in Hydrolysis of an Ester-Type Prodrug o..:

Kono, Kenta ; Nunoya, Ken-ichi ; Nakamura, Yuka...
Molecular Pharmaceutics.  19 (2022)  9 - p. 3450-3450 , 2022
Link: https://doi.org/10.1021/..
 
?
2

Hydrolase Activity of the Genetic Variants of Human Alpha-1..:

Kono, Kenta ; Fujimura, Rui ; Nakamura, Yuka...
Molecular Pharmaceutics.  19 (2022)  3 - p. 798-804 , 2022
Link: https://doi.org/10.1021/..
 
?
3

Robust physiologically based pharmacokinetic model of rifam..:

Asaumi, Ryuta ; Nunoya, Ken‐ichi ; Yamaura, Yoshiyuki..
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  7 - p. 919-933 , 2022
Link: https://doi.org/10.1002/..
 
?
4

Species Difference in Hydrolysis of an Ester-type Prodrug o..:

Kono, Kenta ; Nunoya, Ken-ichi ; Nakamura, Yuka...
Molecular Pharmaceutics.  18 (2021)  5 - p. 1985-1991 , 2021
Link: https://doi.org/10.1021/..
 
?
5

P159 - A novel hydrolytic activation pathway for an ester-t..:

Kono, Kenta ; Fukuchi, Yukina ; Fujimura, Rui...
Drug Metabolism and Pharmacokinetics.  35 (2020)  1 - p. S71 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Expanded Physiologically‐Based Pharmacokinetic Model of Rif..:

Asaumi, Ryuta ; Menzel, Karsten ; Lee, Wooin...
CPT: Pharmacometrics & Systems Pharmacology.  8 (2019)  11 - p. 845-857 , 2019
Link: https://doi.org/10.1002/..
 
?
7

A Human Immortalized Cell-Based Blood–Brain Barrier Tricult..:

Ito, Ryo ; Umehara, Kenta ; Suzuki, Shota...
Molecular Pharmaceutics.  16 (2019)  11 - p. 4461-4471 , 2019
Link: https://doi.org/10.1021/..
 
?
8

Unique Hydrolysis of an Ester-Type Prodrug of Levodopa in H..:

Kono, Kenta ; Fukuchi, Yukina ; Okawa, Hoshimi...
Molecular Pharmaceutics.  16 (2019)  10 - p. 4131-4138 , 2019
Link: https://doi.org/10.1021/..
 
?
9

Comprehensive PBPK Model of Rifampicin for Quantitative Pre..:

Asaumi, Ryuta ; Toshimoto, Kota ; Tobe, Yoshifusa...
CPT: Pharmacometrics & Systems Pharmacology.  7 (2018)  3 - p. 186-196 , 2018
Link: https://doi.org/10.1002/..
 
?
10

Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-..:

Fukuchi, Yukina ; Toshimoto, Kota ; Mori, Takanori...
Journal of Pharmaceutical Sciences.  106 (2017)  9 - p. 2704-2714 , 2017
Link: https://doi.org/10.1016/..
 
?
11

In Vitro Metabolism and Inhibitory Effects of Pranlukast in..:

Yoneda, Kazuhiro ; Matsumoto, Ichiro ; Sutoh, Fumitaka...
Biological and Pharmaceutical Bulletin.  32 (2009)  4 - p. 688-693 , 2009
Link: https://doi.org/10.1248/..
 
?
12

Erratum: In Vitro Metabolism and Inhibitory Effects of Pran..:

Yoneda, Kazuhiro ; Matsumoto, Ichiro ; Sutoh, Fumitaka...
Biological and Pharmaceutical Bulletin.  32 (2009)  7 - p. 1311 , 2009
Link: https://doi.org/10.1248/..
 
?
13

Transmembrane Helix 11 of Multidrug Resistance Protein 1 (M..:

Zhang, Da-Wei ; Nunoya, Kenichi ; Vasa, Monika...
Biochemistry.  43 (2004)  29 - p. 9413-9425 , 2004
Link: https://doi.org/10.1021/..
 
?
14

Genetic polymorphism of CYP2A6 in relation to cancer:

Kamataki, Tetsuya ; Nunoya, Ken-ichi ; Sakai, Yuki..
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis.  428 (1999)  1-2 - p. 125-130 , 1999
Link: https://doi.org/10.1016/..
 
?
15

A new deleted allele in the human cytochrome P450 2A6 (CYP2..:

Nunoya, Ken-ichi ; Yokoi, Tsuyoshi ; Kimura, Kanzo...
Pharmacogenetics.  8 (1998)  3 - p. 239-250 , 1998
Link: https://doi.org/10.1097/..
 
1-15